Join us for a webinar on how advances in target-based drug discovery are reshaping therapeutic design. We’ll explore ...
In drug discovery, virtual screening is a fast and cost-effective way of narrowing down vast chemical libraries to identify the most promising hits, reducing synthesis and testing requirements while ...
TOKYO--(BUSINESS WIRE)--Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) is pleased to announce that its AI drug discovery platform, Elix ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback